Next Article in Journal
Analysis of the Influence of Demographic, Clinical and Physical Factors on the Occurrence of Ocular Complications After Ruthenium-106 and Iodine-125 Brachytherapy as Well as Proton Therapy of Uveal Melanoma
Previous Article in Journal
Clinical AI in Radiology: Foundations, Trends, Applications, and Emerging Directions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 18
Issue 6
10.3390/cancers18060943
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2022, 14(19), 4773.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773

by
Asma Bourefis
1,
Hajira Berredjem
1,*,
Omar Djeffal
2,
Thi Khanh Le
3,
Sophie Giusiano
4 and
Palma Rocchi
3,*
1
Laboratory of Applied Biochemistry and Microbiology, Department of Biochemistry, Faculty of Sciences, Badji Mokhtar-Annaba University, Annaba 23000, Algeria
2
Private Medical Uro-Chirurgical Cabinet, Annaba 23000, Algeria
3
Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, 13273 Marseille, France
4
Department of Pathology, Hôpital Nord, Chemin des Bourrely, Aix Marseille University, CEDEX 20, 13915 Marseille, France
*
Authors to whom correspondence should be addressed.
Cancers 2026, 18(6), 943; https://doi.org/10.3390/cancers18060943
Submission received: 28 February 2026 / Accepted: 4 March 2026 / Published: 13 March 2026
Versions Notes

Text Correction

There was an oversight in the original publication [1]. A correction has been made to the Conflicts of Interest statement: The University of British Columbia has submitted patent applications on Apatorsen, an antisense inhibitor of Hsp27, listing P.R. as an inventor. This IP has been licenced to OncoGenex Technologies, a Vancouver-based biotechnology company. P.R. is a co-founder of SilonTx (https://silontx.com), a biotech company started in April 2024, focusing on precision medicine and nucleic acid therapeutics.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Bourefis, A.; Berredjem, H.; Djeffal, O.; Le, T.K.; Giusiano, S.; Rocchi, P. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bourefis, A.; Berredjem, H.; Djeffal, O.; Le, T.K.; Giusiano, S.; Rocchi, P. Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773. Cancers 2026, 18, 943. https://doi.org/10.3390/cancers18060943

AMA Style

Bourefis A, Berredjem H, Djeffal O, Le TK, Giusiano S, Rocchi P. Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773. Cancers. 2026; 18(6):943. https://doi.org/10.3390/cancers18060943

Chicago/Turabian Style

Bourefis, Asma, Hajira Berredjem, Omar Djeffal, Thi Khanh Le, Sophie Giusiano, and Palma Rocchi. 2026. "Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773" Cancers 18, no. 6: 943. https://doi.org/10.3390/cancers18060943

APA Style

Bourefis, A., Berredjem, H., Djeffal, O., Le, T. K., Giusiano, S., & Rocchi, P. (2026). Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773. Cancers, 18(6), 943. https://doi.org/10.3390/cancers18060943

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop